GHK-Cu is a copper peptide commonly discussed for skin quality, collagen support, elasticity, healthy aging, and regenerative wellness programs
these issues are out of scope for this final rule
Discard any vial showing turbidity, suspended particulate, yellowing, decolourisation, or visible precipitate
The NHS schedule for treating B12 deficiency is a loading dose of 1mg hydroxocobalamin by intramuscular injection every two to three days for two weeks, then a maintenance dose every two to three months for life when the cause is non-dietary
Best peptide approach : BPC-157 + GHK-Cu Protocol : BPC-157: 500mcg twice daily (12+ weeks) GHK-Cu: 2mg daily (8-12 weeks) Long-term commitment needed Why this works : BPC-157 addresses cartilage and inflammation GHK-Cu potent anti-inflammatory Combined approach targets multiple mechanisms Expected results : 40-60% pain reduction, improved mobility, less morning stiffness
It is also important to note that different conditions affect HbA1c in different ways: Haemolytic anaemia and acute blood loss shorten red cell lifespan and tend to lower HbA1c Iron deficiency anaemia is associated with increased HbA1c, likely due to prolonged red cell survival Haemoglobin variants (haemoglobinopathies) can cause variable or assay-dependent interference the effect depends on the specific variant and the HbA1c method used B12 or folate deficiency alters erythropoiesis and red cell indices, making HbA1c potentially unreliable in either direction Clinicians should therefore: Review the full blood count (FBC) alongside HbA1c Check serum B12 and folate when anaemia or macrocytosis (raised mean corpuscular volume, MCV) is identified Consider alternative glucose assessment methods specifically fasting plasma glucose or a 75 g OGTT for diagnostic purposes, or self-monitored blood glucose (SMBG) or fructosamine/glycated albumin for interim monitoring when HbA1c is unreliable Not sure where to start
